Incysus Announces Preclinical Data Presentations of γδ T Cell Immunotherapy Programs at Upcoming Medical … – GlobeNewswire (press release)
|
Incysus Announces Preclinical Data Presentations of γδ T Cell Immunotherapy Programs at Upcoming Medical …
GlobeNewswire (press release) The research conducted at UAB provides a demonstration of the mechanisms related to a Drug Resistant Immunotherapy (DRI) using activated γδ T cells for treating cancer. Incysus and UAB are moving quickly towards an investigational new drug application … |
